Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
Reset 

Clinical Study Featuring Pursuit Vascular ClearGuard® HD Antimicrobial Barrier Caps Receives Prestigious Editors' Choice Award

MAPLE GROVE, Minn., June 19, 2018 /PRNewswire/ -- Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Caps, the leading antimicrobial device for catheter-based dialysis patients, today announced that publication of a clinical study in the American Journal of Kidney Diseases... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Pursuit Vascular, Inc.

BiondVax Receives Its First EUR6M Tranche Disbursement From the European Investment Bank (EIB)

NESS ZIONA, Israel, June 19, 2018 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), developer of M?001, a clinical phase Universal Influenza Vaccine candidate, announced today the receipt of a EUR6 million disbursement from the European Investment Bank (EIB). These funds are the first... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer

MADISON, Wis., June 19, 2018 /PRNewswire/ -- The national colon cancer screening movement led by golfer Jerry Kelly will be front and center when the PGA TOUR Champions comes to University Ridge Golf Course June 22-24, 2018 for the American Family Insurance Championship (AmFam Championship).... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Exact Sciences Corp.

Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label

THOUSAND OAKS, Calif., June 19, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted a full marketing authorization for BLINCYTO(® )(blinatumomab) based on the overall survival (OS) data from the Phase 3 TOWER study in adult patients... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  AMGEN, INC.

Doudna-Charpentier Team Awarded Patent for CRISPR-Cas9

BERKELEY, Calif., June 19, 2018 /PRNewswire/ -- The University of California announced today that the United States Patent and Trademark Office has granted patent number 10,000,772 covering the use of CRISPR-Cas9 gene editing... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

TransPerfect Life Sciences to Lead Collaboration Workshop and Release New Trial Interactive E-Clinical Technology at DIA 2018

BOSTON, June 19, 2018 /PRNewswire/ -- TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced highlights of its presence... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  TransPerfect Trial Interactive | TransPerfect

Seattle Children's Opens Immunotherapy Trial For Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain

SEATTLE, June 19, 2018 /PRNewswire-USNewswire/ -- Seattle Children's has opened a pioneering chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory HER2-positive central nervous system (CNS) tumors where CAR T cells will be delivered... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

St. Jude Children's Research Hospital Marks World Sickle Cell Day on June 19

MEMPHIS, Tenn., June 19, 2018 /PRNewswire-USNewswire/ -- Today, June 19(th), is World Sickle Cell Day and Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  St. Jude Children's Research Hospital

Findings From Kalorama Infectious Disease Test Products Study Announced

ROCKVILLE, Md., June 19, 2018 /PRNewswire/ -- The global market for infectious disease products will demonstrate a revenue growth rate 60% higher than the overall world market for in vitro diagnostics. This is according to healthcare market research firm Kalorama Information. And tests for... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Medisafe Announces Partnership with Boehringer Ingelheim to Support U.S. Pradaxa Patients

BOSTON, June 19, 2018 /PRNewswire/ -- Medisafe(®), the leading personalized mobile health platform for medication management with over four million patient and caregiver users globally, today unveiled a partnership with Boehringer... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Boehringer Ingelheim Pharmaceuticals, Inc | Boehringer Ingelheim, Ridgefield | Boehringer Ingelheim Fremont, Inc.

New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatology

MENLO PARK, Calif., June 19, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, has formed a Special Advisory Council of thought leaders from various disciplines to help the company embrace patient... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  BioPharmX, Inc.

8,000 AbbVie Employees Volunteer Across Five Continents During Fifth-Annual "Week of Possibilities"

NORTH CHICAGO, Ill., June 19, 2018 /PRNewswire/ -- AbbVie, a global biopharmaceutical company, has teamed up with leading nonprofits to launch its fifth annual "Week of Possibilities" global volunteering program. In more than 50 countries, approximately 8,000 AbbVie employees will give... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  ABBVIE INC.

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

SAN DIEGO, June 19, 2018 /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious diseases, including cytomegalovirus... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Artemis Therapeutics Inc.

Herzing University Receives Accreditation for BSN Program at Kenosha Campus

KENOSHA, Wis., June 19, 2018 /PRNewswire/ -- The Bachelor of Science in Nursing (BSN) program at Herzing University's Kenosha campus has been approved for a five-year accreditation by the Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Positive Knee Preservation Outcomes Using the Innovative Arthrosurface Inlay PF Wave(TM)

FRANKLIN, Mass., June 19, 2018 /PRNewswire/ -- Arthrosurface, Inc. announced today that midterm clinical results reconfirmed joint preservation in patellofemoral (PF) surgery with the PF Wave(TM) Implant System. 5-year results presented by Dr. Jonas Pogorzelski at the recent ESSKA Congress in... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Arthrosurface Inc.

Oxitec to Apply New Generation of Self-limiting Mosquito Technology to Malaria-spreading Mosquitoes

OXFORD, England, June 19, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Intrexon Corporation

Yoichiro Ito, MD, Recognized for Development of Cancer Chemical Separation Method

ROCKVILLE, Md., June 19, 2018 /PRNewswire/ -- Yoichiro Ito, MD, is a distinguished biographee of Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are chosen from among a pool of the most prominent professionals and are selected on the basis of current... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Novanta to Present at the CJS Securities 18th Annual "New Ideas" Summer Conference on Tuesday, July 10, 2018

BEDFORD, Mass., June 19, 2018 /PRNewswire/ -- Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Janie Goddard, President of Novanta's JADAK business... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products

LAVAL, QC, June 19, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), today announced that it entered into a multi-year agreement with Canopy Growth (TSX: WEED) (NYSE: CGC). Under the terms of the agreement, Neptune will... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Neptune Technologies & Bioressources Inc.

Cronos Australia is Granted Manufacturing License

TORONTO, June 19, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that Cronos Australia Pty Ltd. ("Cronos Australia") has been granted a medicinal cannabis Manufacture License by the Australian... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Cronos Group Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
to the top ↑